In a post hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) trial, we utilized a marginal structural model to quantify the relationship between annual urine albumin:creatinine ratio (UACR) measurements and new-onset AF. This evidence concerns the gene ALB and atrial fibrillation.